Health Trials

Visceral Sensitivity in IBD (Irritable Bowel Disease) and IBS (Irritable Bowel Syndrome)

ConditionsIBSUlcerative Colitis, ActiveUlcerative Colitis, Remission (3a: With IBS Symptoms, 3b: Without IBS Symptoms)Healthy ControlsCrohn's Disease, ActiveCrohn's Disease, Remission (6a: With IBS Symptoms, 6b: Without IBS Symptoms)
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorKU Leuven

About this trial

Aim:

More insight in pathogenesis of IBS and IBD. Samples are collected in context of an European research project.

Eligibility criteria

Qualifiers

Irritable Bowel Syndrome (IBS) (ROME III criteria)

No obvious organic explanation for the IBS symptoms

Medication which affects the gastrointestinal motility or perception should be stopped at least 24 hours before the study

diagnosis of ulcerative colitis (Confirmed by at least one sigmoidoscopy)

Disqualifiers

co-morbidity: severe kidney- and/or liver disease or thyroid abnormalities and impaired clotting

Abdominal chirurgy (except for an uncomplicated appendectomy)

Trial design

Treatments tested in this trial

  • Sample collection

Treatment groups

99,999,999 Participants
are divided into 1 treatment group

Sponsors and collaborators

KU Leuven

Lead sponsor

Source ClinicalTrials.gov